PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SNDX vs. WMT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SNDX and WMT is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

SNDX vs. WMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Syndax Pharmaceuticals, Inc. (SNDX) and Walmart Inc. (WMT). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%AugustSeptemberOctoberNovemberDecember2025
-39.14%
31.04%
SNDX
WMT

Key characteristics

Sharpe Ratio

SNDX:

-0.76

WMT:

4.31

Sortino Ratio

SNDX:

-0.87

WMT:

6.30

Omega Ratio

SNDX:

0.88

WMT:

1.81

Calmar Ratio

SNDX:

-0.69

WMT:

13.08

Martin Ratio

SNDX:

-1.83

WMT:

41.82

Ulcer Index

SNDX:

21.55%

WMT:

1.82%

Daily Std Dev

SNDX:

51.88%

WMT:

17.66%

Max Drawdown

SNDX:

-78.98%

WMT:

-77.24%

Current Drawdown

SNDX:

-52.35%

WMT:

-3.86%

Fundamentals

Market Cap

SNDX:

$1.18B

WMT:

$737.47B

EPS

SNDX:

-$3.64

WMT:

$2.42

PEG Ratio

SNDX:

0.00

WMT:

2.76

Total Revenue (TTM)

SNDX:

$16.00M

WMT:

$673.82B

Gross Profit (TTM)

SNDX:

-$28.34M

WMT:

$166.41B

EBITDA (TTM)

SNDX:

-$224.46M

WMT:

$38.20B

Returns By Period

In the year-to-date period, SNDX achieves a 4.46% return, which is significantly higher than WMT's 1.60% return.


SNDX

YTD

4.46%

1M

-11.25%

6M

-39.14%

1Y

-39.00%

5Y*

10.02%

10Y*

N/A

WMT

YTD

1.60%

1M

-1.95%

6M

31.04%

1Y

74.94%

5Y*

20.67%

10Y*

14.21%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SNDX vs. WMT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNDX
The Risk-Adjusted Performance Rank of SNDX is 1010
Overall Rank
The Sharpe Ratio Rank of SNDX is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of SNDX is 1414
Sortino Ratio Rank
The Omega Ratio Rank of SNDX is 1414
Omega Ratio Rank
The Calmar Ratio Rank of SNDX is 99
Calmar Ratio Rank
The Martin Ratio Rank of SNDX is 22
Martin Ratio Rank

WMT
The Risk-Adjusted Performance Rank of WMT is 9999
Overall Rank
The Sharpe Ratio Rank of WMT is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of WMT is 9999
Sortino Ratio Rank
The Omega Ratio Rank of WMT is 9898
Omega Ratio Rank
The Calmar Ratio Rank of WMT is 100100
Calmar Ratio Rank
The Martin Ratio Rank of WMT is 100100
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SNDX vs. WMT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Syndax Pharmaceuticals, Inc. (SNDX) and Walmart Inc. (WMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SNDX, currently valued at -0.76, compared to the broader market-4.00-2.000.002.00-0.764.31
The chart of Sortino ratio for SNDX, currently valued at -0.87, compared to the broader market-4.00-2.000.002.004.00-0.876.30
The chart of Omega ratio for SNDX, currently valued at 0.88, compared to the broader market0.501.001.502.000.881.81
The chart of Calmar ratio for SNDX, currently valued at -0.69, compared to the broader market0.002.004.006.00-0.6913.08
The chart of Martin ratio for SNDX, currently valued at -1.83, compared to the broader market-10.000.0010.0020.00-1.8341.82
SNDX
WMT

The current SNDX Sharpe Ratio is -0.76, which is lower than the WMT Sharpe Ratio of 4.31. The chart below compares the historical Sharpe Ratios of SNDX and WMT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00AugustSeptemberOctoberNovemberDecember2025
-0.76
4.31
SNDX
WMT

Dividends

SNDX vs. WMT - Dividend Comparison

SNDX has not paid dividends to shareholders, while WMT's dividend yield for the trailing twelve months is around 0.91%.


TTM20242023202220212020201920182017201620152014
SNDX
Syndax Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
WMT
Walmart Inc.
0.91%0.92%1.45%1.58%1.52%1.50%1.78%2.23%2.07%2.89%3.20%2.24%

Drawdowns

SNDX vs. WMT - Drawdown Comparison

The maximum SNDX drawdown since its inception was -78.98%, roughly equal to the maximum WMT drawdown of -77.24%. Use the drawdown chart below to compare losses from any high point for SNDX and WMT. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-52.35%
-3.86%
SNDX
WMT

Volatility

SNDX vs. WMT - Volatility Comparison

Syndax Pharmaceuticals, Inc. (SNDX) has a higher volatility of 16.96% compared to Walmart Inc. (WMT) at 5.42%. This indicates that SNDX's price experiences larger fluctuations and is considered to be riskier than WMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%AugustSeptemberOctoberNovemberDecember2025
16.96%
5.42%
SNDX
WMT

Financials

SNDX vs. WMT - Financials Comparison

This section allows you to compare key financial metrics between Syndax Pharmaceuticals, Inc. and Walmart Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab